Arl2-Mediated Allosteric Release of Farnesylated KRas4B from Shuttling Factor PDEδ

Area of Science:

• Molecular biology
• Cellular signaling
• Biophysics

Background:

• Ras proteins, particularly KRas4B, require precise plasma membrane (PM) localization for their signaling functions.
• KRas4B and other Ras proteins interact with the PDEδ shuttling protein via their farnesylated hypervariable regions (HVRs) for transport to the PM.
• Arf-like protein 2 (Arl2) is known to facilitate Ras release from PDEδ at the PM, but the underlying mechanism remains elusive.

Purpose of the Study:

• To elucidate the detailed molecular mechanism by which Arl2 mediates the release of KRas4B from PDEδ.
• To investigate the role of allosteric changes in PDEδ upon Arl2 binding.
• To provide a mechanistic basis for potential therapeutic strategies targeting KRas4B.

Main Methods:

• All-atom molecular dynamics simulations of ternary Arl2-PDEδ-KRas4B HVR complexes.
• Analysis of structural changes and interactions within the simulated complexes.
• Site-directed mutagenesis of key PDEδ residues to assess their role in the release process.

Main Results:

• Arl2 binding to PDEδ weakens the interaction with the farnesylated KRas4B HVR.
• Allosteric conformational changes in PDEδ, involving the β6 strand and other residues, lead to compression of the hydrophobic pocket, expelling the HVR.
• Mutations in PDEδ residues critical for these allosteric changes abolish the release of KRas4B.

Conclusions:

• The study reveals a precise allosteric mechanism for Arl2-mediated release of KRas4B from PDEδ.
• Understanding this mechanism is crucial as mutant Ras proteins are prevalent in cancers.
• The findings may inform the development of novel therapeutics aimed at inhibiting oncogenic KRas4B signaling by interfering with its release from PDEδ.